119 related articles for article (PubMed ID: 23861152)
1. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Gebhard MP; Noack F; Bruchhage KL; Schild SE
Strahlenther Onkol; 2014 Jan; 190(1):68-74. PubMed ID: 23861152
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F
Strahlenther Onkol; 2013 Oct; 189(10):849-55. PubMed ID: 23959264
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.
Seibold ND; Schild SE; Gebhard MP; Noack F; Schröder U; Rades D
Strahlenther Onkol; 2013 Jul; 189(7):559-65. PubMed ID: 23700207
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Rades D; Huttenlocher S; Seibold ND; Gebhard MP; Thorns C; Hasselbacher K; Wollenberg B; Schild SE
BMC Cancer; 2015 Mar; 15():102. PubMed ID: 25868613
[TBL] [Abstract][Full Text] [Related]
8. Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Hoffmann A; Gebhard MP; Noack F; Thorns C; Schild SE
Strahlenther Onkol; 2013 Oct; 189(10):856-60. PubMed ID: 23868550
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Rades D; Seibold ND; Gebhard MP; Noack F; Schild SE; Thorns C
Strahlenther Onkol; 2011 Oct; 187(10):626-32. PubMed ID: 21932027
[TBL] [Abstract][Full Text] [Related]
10. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
[TBL] [Abstract][Full Text] [Related]
11. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).
Rades D; Setter C; Dunst J; Dahl O; Schild SE; Noack F
Strahlenther Onkol; 2010 Jun; 186(6):307-14. PubMed ID: 20437013
[TBL] [Abstract][Full Text] [Related]
14. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.
Seidl D; Janssen S; Strojan P; Bajrovic A; Schild SE; Rades D
Anticancer Res; 2016 May; 36(5):2523-6. PubMed ID: 27127167
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
18. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
19. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
20. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
